Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Recruiting

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.

Study Type:    Interventional

Study Design:    

Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title:    Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma

Conditions:  CTCL

Intervention:  Drug:  Doxycycline monohydrate   

Phase:  Phase 2

External Link:  https://clinicaltrials.gov/ct2/show/NCT02341209